OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
Wenxiao Jiang, Jun Xia, Shangdan Xie, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100683-100683
Closed Access | Times Cited: 114
Wenxiao Jiang, Jun Xia, Shangdan Xie, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100683-100683
Closed Access | Times Cited: 114
Showing 26-50 of 114 citing articles:
Long non‐coding RNA NEAT1 promotes aerobic glycolysis and progression of cervical cancer through WNT /β‐catenin/PDK1 axis
Min Su, Ziyan Liang, Shidong Shan, et al.
Cancer Medicine (2024) Vol. 13, Iss. 9
Open Access | Times Cited: 5
Min Su, Ziyan Liang, Shidong Shan, et al.
Cancer Medicine (2024) Vol. 13, Iss. 9
Open Access | Times Cited: 5
Non-Coding RNA: A Key Regulator in the Glutathione-GPX4 Pathway of Ferroptosis
Md Sadique Hussain, Gaurav Gupta, Moyad Shahwan, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1222-1234
Open Access | Times Cited: 5
Md Sadique Hussain, Gaurav Gupta, Moyad Shahwan, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1222-1234
Open Access | Times Cited: 5
Role of Hypoxia-Associated Long Noncoding RNAs in Cancer Chemo-Therapy Resistance
Muhammad Affan Elahi, Aamira Tariq, Ambrin Malik, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 936-936
Open Access
Muhammad Affan Elahi, Aamira Tariq, Ambrin Malik, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 936-936
Open Access
Long noncoding RNA loss in immune suppression in cancer
Qingsong Hu, Sergey D. Egranov, Chunru Lin, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107591-107591
Open Access | Times Cited: 47
Qingsong Hu, Sergey D. Egranov, Chunru Lin, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107591-107591
Open Access | Times Cited: 47
Regulation of Long Non-Coding RNAs by Plant Secondary Metabolites: A Novel Anticancer Therapeutic Approach
Mohammad Reza Kalhori, Hamid Khodayari, Saeed Khodayari, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1274-1274
Open Access | Times Cited: 33
Mohammad Reza Kalhori, Hamid Khodayari, Saeed Khodayari, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1274-1274
Open Access | Times Cited: 33
Long Intergenic Noncoding RNA00265 Enhances Cell Viability and Metastasis via Targeting miR-485-5p/USP22 Axis in Osteosarcoma
Ting Chen, Jinxin Liu, He Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Ting Chen, Jinxin Liu, He Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models
Vilma Petrikaitė, Nicola d’Avanzo, Christian Celia, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100956-100956
Closed Access | Times Cited: 12
Vilma Petrikaitė, Nicola d’Avanzo, Christian Celia, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100956-100956
Closed Access | Times Cited: 12
The Roles of ceRNAs-Mediated Autophagy in Cancer Chemoresistance and Metastasis
Huilin Zhang, Bingjian Lü
Cancers (2020) Vol. 12, Iss. 10, pp. 2926-2926
Open Access | Times Cited: 37
Huilin Zhang, Bingjian Lü
Cancers (2020) Vol. 12, Iss. 10, pp. 2926-2926
Open Access | Times Cited: 37
Targeted nanomedicine modalities for prostate cancer treatment
Lital Cohen, Yoav D. Livney, Yehuda G. Assaraf
Drug Resistance Updates (2021) Vol. 56, pp. 100762-100762
Closed Access | Times Cited: 30
Lital Cohen, Yoav D. Livney, Yehuda G. Assaraf
Drug Resistance Updates (2021) Vol. 56, pp. 100762-100762
Closed Access | Times Cited: 30
Promising Advances in LINC01116 Related to Cancer
Yating Xu, Xiao Yu, Menggang Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 28
Yating Xu, Xiao Yu, Menggang Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 28
LINC01094/SPI1/CCL7 Axis Promotes Macrophage Accumulation in Lung Adenocarcinoma and Tumor Cell Dissemination
Zhuo Wu, Xue Bai, Zhengbo Lu, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 21
Zhuo Wu, Xue Bai, Zhengbo Lu, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 21
The role of lncRNA OIP5-AS1 in cancer development and progression
Cheng Zheng, Man Chu, Qiuli Chen, et al.
APOPTOSIS (2022) Vol. 27, Iss. 5-6, pp. 311-321
Closed Access | Times Cited: 19
Cheng Zheng, Man Chu, Qiuli Chen, et al.
APOPTOSIS (2022) Vol. 27, Iss. 5-6, pp. 311-321
Closed Access | Times Cited: 19
Unraveling diverse roles of noncoding RNAs in various human papillomavirus negative cancers
Xin Chen, Yi Liu, Hejing Liu, et al.
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108188-108188
Closed Access | Times Cited: 18
Xin Chen, Yi Liu, Hejing Liu, et al.
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108188-108188
Closed Access | Times Cited: 18
Exploring the interplay of natural products and long non-coding RNAs in colorectal cancer: pathogenesis, diagnosis, and overcoming drug resistance
Hanan Elimam, Mahmoud Gomaa Eldeib, Esma Z Kizilaslan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 3
Hanan Elimam, Mahmoud Gomaa Eldeib, Esma Z Kizilaslan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 3
Long noncoding RNAs have pivotal roles in chemoresistance of acute myeloid leukemia
Mehrdad Izadirad, Leila Jafari, Alva Rani James, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 7, pp. 1735-1743
Closed Access | Times Cited: 25
Mehrdad Izadirad, Leila Jafari, Alva Rani James, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 7, pp. 1735-1743
Closed Access | Times Cited: 25
Role of long non-coding RNA H19 in therapy resistance of digestive system cancers
Jingting Wang, Xiao Ma, Si Hai, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 23
Jingting Wang, Xiao Ma, Si Hai, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 23
Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
Man Wang, Lijie Zhu, Xiaoxu Yang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Man Wang, Lijie Zhu, Xiaoxu Yang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
<p>Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis</p>
Chao Guo, Ming Gong, Zhenling Li
Cancer Management and Research (2020) Vol. Volume 12, pp. 5845-5855
Open Access | Times Cited: 23
Chao Guo, Ming Gong, Zhenling Li
Cancer Management and Research (2020) Vol. Volume 12, pp. 5845-5855
Open Access | Times Cited: 23
The Functional Role of Long Non-Coding RNAs in Melanoma
Michał Woźniak, Małgorzata Czyż
Cancers (2021) Vol. 13, Iss. 19, pp. 4848-4848
Open Access | Times Cited: 21
Michał Woźniak, Małgorzata Czyż
Cancers (2021) Vol. 13, Iss. 19, pp. 4848-4848
Open Access | Times Cited: 21
Identification of associations between lncRNA and drug resistance based on deep learning and attention mechanism
Meihong Gao, Xuequn Shang
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Meihong Gao, Xuequn Shang
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Long Noncoding RNAs in Taxane Resistance of Breast Cancer
Hailong Chen, Mengwen Zhang, Yongchuan Deng
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12253-12253
Open Access | Times Cited: 8
Hailong Chen, Mengwen Zhang, Yongchuan Deng
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12253-12253
Open Access | Times Cited: 8
A combination of cuproptosis and lncRNAs predicts the prognosis and tumor immune microenvironment in cervical cancer
Yitong Huang, Chenxiang Pan, Suni Wu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Yitong Huang, Chenxiang Pan, Suni Wu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein
Kailin Chen, Sai-Wei Huang, Ji‐Jin Yao, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101111-101111
Closed Access | Times Cited: 2
Kailin Chen, Sai-Wei Huang, Ji‐Jin Yao, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101111-101111
Closed Access | Times Cited: 2
Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting
Deepti Singh, Mohammad Afsar Khan, Hifzur R. Siddique
Molecular Biology Reports (2020) Vol. 47, Iss. 7, pp. 5569-5585
Closed Access | Times Cited: 23
Deepti Singh, Mohammad Afsar Khan, Hifzur R. Siddique
Molecular Biology Reports (2020) Vol. 47, Iss. 7, pp. 5569-5585
Closed Access | Times Cited: 23
The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer
Yi Liu, Hejing Liu, Bo Sheng, et al.
APOPTOSIS (2022) Vol. 27, Iss. 9-10, pp. 685-696
Closed Access | Times Cited: 12
Yi Liu, Hejing Liu, Bo Sheng, et al.
APOPTOSIS (2022) Vol. 27, Iss. 9-10, pp. 685-696
Closed Access | Times Cited: 12
